New diabetes pill aims to lower blood sugar and weight
NCT ID NCT07321678
Summary
This study is testing whether a new oral medication called ASC30 can help control blood sugar levels in people with type 2 diabetes. Researchers will compare the pill against a placebo (inactive pill) in 100 participants over 13 weeks. The study will measure changes in blood sugar markers and body weight to see if the treatment is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ascletis Clinical Site
RECRUITINGRiverside, California, 92506, United States
-
Ascletis Clinical Site
RECRUITINGSan Jose, California, 95128, United States
-
Ascletis Clinical Site
RECRUITINGDenver, Colorado, 80246, United States
-
Ascletis Clinical Site
RECRUITINGMiami, Florida, 33143, United States
-
Ascletis Clinical Site
RECRUITINGMiami, Florida, 33172, United States
-
Ascletis Clinical Site
RECRUITINGDecatur, Georgia, 30030, United States
-
Ascletis Clinical Site
RECRUITINGSpringfield, Missouri, 65802, United States
-
Ascletis Clinical Site
RECRUITINGSan Antonio, Texas, 78240, United States
Conditions
Explore the condition pages connected to this study.